Everpar Advisors LLC Astrazeneca PLC Transaction History
Everpar Advisors LLC
- $270 Billion
- Q4 2025
A detailed history of Everpar Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Everpar Advisors LLC holds 6,043 shares of AZN stock, worth $540,244. This represents 0.21% of its overall portfolio holdings.
Number of Shares
6,043
Previous 7,043
14.2%
Holding current value
$540,244
Previous $540 Million
2.81%
% of portfolio
0.21%
Previous 0.21%
Shares
9 transactions
Others Institutions Holding AZN
# of Institutions
1,498Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...